Patents by Inventor Michael Rodolf

Michael Rodolf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targets of
    Patent number: 9597387
    Abstract: The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: March 21, 2017
    Assignee: Aridis Pharmaceuticals, Inc.
    Inventors: Simon Urwyler, Markus Haake, Michael Rodolf
  • Novel Targets of Acinetobacter Baumannii
    Publication number: 20150023999
    Abstract: The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.
    Type: Application
    Filed: November 29, 2012
    Publication date: January 22, 2015
    Inventors: Simon Urwyler, Markus Haake, Michael Rodolf